ENKI-CLINICAL Terms of Use

Developer / Owner: Dr. Amir Fadhel (ENKI-CLINICAL)

Effective Date: February 8, 2026

Scope of Application

These Terms of Use apply to all ENKI-CLINICAL products and services, including but not limited to:

• ENKI-CLINICAL SUITE (integrated platform)
• Ultimate AVBG Calculator (arterial/venous blood gas analysis)
• ICU IV Infusion Calculator (critical care medication dosing)
• AIE™ - Antimicrobial Intelligence Engine
• INE™ - ICU Nutrition Engine
• CRRT Engine (renal replacement therapy)

By requesting access to ANY ENKI-CLINICAL product, you agree to these Terms in their entirety.

1) Purpose and Clinical Disclaimer (Non-negotiable)

ENKI-CLINICAL products are clinical decision-support tools intended to assist qualified healthcare professionals. They do not provide medical advice and do not replace:

• bedside clinical judgment,
• local protocols,
• specialist consultation,
• or institutional policies.

The user remains fully responsible for all clinical decisions, prescriptions, calculations, and patient outcomes.

2) Intended Users Only

These products are intended only for:

• licensed physicians, pharmacists, nurses, or trained healthcare staff operating under supervision,
• or trainees using them under a recognized clinical governance structure.

They are not intended for laypersons, self-treatment, or non-clinical use.

3) Transparency When Using the Tool

The user agrees to be transparent and ethically compliant when ENKI-CLINICAL contributes to decisions, including when:

• documenting notes,
• communicating with patients/families,
• presenting decisions to colleagues,
• reporting incidents.

If an institution requires disclosure of decision-support tools, the user must comply.

4) Trial Period Rules (Quality Feedback Duty)

During any trial period, the user agrees:

• to test carefully before relying on the tool,
• to report suspected errors or unexpected behaviors to the developer,
• and to avoid unsafe reliance for high-risk decisions without independent verification.

The trial exists specifically to evaluate suitability for the user's setting and devices.

5) Verification Duty (User's Responsibility)

The user agrees to verify outputs against clinical reality and basic safety checks, including (as applicable):

• unit correctness,
• patient weight/age entry accuracy,
• renal/hepatic context,
• contraindications and interactions (where relevant),
• lab sampling timing and physiologic plausibility.

6) No Emergency Guarantee

All products are provided "as-is." They are not guaranteed to be available, accurate, complete, uninterrupted, or error-free in emergencies or unstable environments.

7) Prohibited Misuse

The user must not:

• use any product to practice outside their scope,
• attempt to reverse-engineer, copy, clone, resell, distribute, or share activation access,
• remove branding, notices, disclaimers, or license controls,
• misrepresent any product as an official hospital system unless formally approved,
• use any product for illegal, deceptive, or harmful purposes.

8) License, Access, and Compliance

Access may require an approval workflow and activation/confirmation code. The developer may:

• refuse access,
• revoke access for misuse,
• require re-verification for security or governance reasons.

9) Payments and Refunds

All purchases are final. No refunds after purchase, including claims of "not useful," "device incompatibility," "change of mind," or "unused."

10) Limitation of Liability

To the maximum extent permitted by law, the developer is not liable for:

• clinical outcomes,
• direct or indirect damages,
• missed diagnoses,
• incorrect dosing decisions,
• lost profits,
• device or connectivity failures,
• or any harm arising from use or misuse.

The user accepts full responsibility for clinical use and verification.

11) Indemnity

The user agrees to indemnify and hold harmless the developer from claims arising from:

• misuse,
• practice outside scope,
• failure to verify,
• failure to follow local policy,
• unauthorized distribution.

12) Updates, Changes, and Versioning

The developer may update features, terms, and access controls. Continued use after an update means the user accepts the updated Terms.

13) Governing Law and Disputes

Governing law: Republic of Iraq. Disputes should first attempt resolution by direct communication. If unresolved, disputes proceed under the chosen jurisdiction.

14) Contact

Support / reports: dr.amiralshimmarii@gmail.com

15) Acceptance

By checking the acceptance box and submitting an access request, the user confirms:

• they read the Terms of Use,
• they understand them,
• and they agree to be bound by them.